Innova tests’ bad results headed for the bin., page-3

This latest test results by the university of Burlington is even lightyears worse , sensitivity of just 3%? (the proportion of people with covid-19 who tested positive) and that 58% of the positives were false positives & Innova get paid $1.8 billion in 6 months ? common Derek & Jack , ADO need to scream blue murder with false tests getting UK government's nod like that ? these clowns must have been making it very hard for ADO to enter the the UK, We have Scomo and ambassador George Brandis talking trade ???? I expect ADO to get traction on this farce.

https://www.bmj.com/content/371/bmj.m4950
News
Covid-19: UK regulator approves lateral flow test for home use despite accuracy concerns

BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4950 (Published 23 December 2020)Cite this as: BMJ 2020;371:m4950
Read our latest coverage of the coronavirus outbreak

• Article
• Related content
• Metrics
• Responses

1. Elisabeth Mahase

Author affiliations
The UK’s regulator has approved the Innova lateral flow covid-19 test for people to self-administer despite warnings from some testing experts that it is inaccurate and may give people a false sense of security.
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced that it had issued authorisation to the Department of Health and Social Care on 23 December to allow the use of the antigen lateral flow test for home testing to “detect infection in asymptomatic individuals.”
“A negative test result means that the test has not detected the presence of the covid-19 virus, at the time the test was taken,” it said. “Anyone receiving a negative test result should continue to follow the latest guidance for their area.”
This comes after Jon Deeks, professor of biostatistics at the University of Birmingham, shared unpublished results on social media from the mass testing programmes at the University of Birmingham and Scottish universities suggesting that the lateral flow tests had a sensitivity of just 3% (the proportion of people with covid-19 who tested positive) and that 58% of the positives were false positives.1 Deeks, who also leads the Cochrane Collaboration’s covid-19 test evaluation activities, said that the results would be available as a preprint soon.
Previous data from the Liverpool mass testing pilot programme found that lateral flow tests detected just 48.89% of covid-19 infections in asymptomatic people when compared with a polymerase chain reaction (PCR) test. It also found that the Innova Lateral Flow SARS-CoV-2 antigen test failed to detect three in 10 cases with the highest viral loads.2